What is Proton Intelligence?
Proton Intelligence is a medical technology innovator dedicated to transforming the management of hyperkalemia. The company is currently developing a proprietary, real-time, on-demand potassium monitoring wearable device designed to assist clinicians in the precise treatment of patients suffering from chronic kidney disease and heart failure. By providing continuous data, the device aims to mitigate the risks associated with high potassium levels, which currently affect millions of patients globally. The company's market position is defined by its commitment to bridging the gap between intermittent laboratory testing and the need for immediate, actionable clinical insights, thereby enhancing patient safety and optimizing therapeutic outcomes for healthcare providers.
How much funding has Proton Intelligence raised?
Proton Intelligence has raised a total of $7M across 1 funding round:
Angel/Seed
$7M
Angel/Seed (2024): $7M with participation from 15th Rock Ventures, SOSV, EXOR, Tenmile, and We Venture
Key Investors in Proton Intelligence
15th Rock Ventures
15th Rock is a venture capital firm specializing in the enhancement of human capabilities through technology, with a focus on robotics and AI-driven innovation.
SOSV
SOSV is a prominent multi-stage venture capital investor that provides both intellectual and financial capital to accelerate the growth of high-impact startups.
EXOR
Exor is a diversified investment holding company that makes medium to long-term strategic investments across various global industrial and service sectors.
What's next for Proton Intelligence?
With this recent capital injection, Proton Intelligence is poised to accelerate its research and development roadmap, focusing on clinical validation and the refinement of its wearable monitoring platform. The strategic roadmap includes scaling manufacturing capabilities and navigating the complex regulatory landscape required for medical device commercialization. As the company moves forward, it will likely prioritize partnerships with healthcare systems to integrate its technology into standard care protocols for high-risk patient populations. The focus remains on achieving scalable growth while maintaining the rigorous standards necessary for clinical adoption in the global health market.
See full Proton Intelligence company page
